Application 209949
- Type
- NDA
- Sponsor
- XELLIA PHARMS APS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DAPTOMYCIN | DAPTOMYCIN | POWDER;IV (INFUSION) | 350MG/VIAL | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N209949-001 | DAPTOMYCIN | DAPTOMYCIN | 350MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-10-20 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N209949-001 | DAPTOMYCIN | 350MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-10-20 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N209949-001 | DAPTOMYCIN | 350MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-10-20 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N209949-001 | DAPTOMYCIN | 350MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-10-20 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N209949-001 | DAPTOMYCIN | 350MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-10-20 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N209949-001 | DAPTOMYCIN | 350MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-10-20 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Daptomycin | DAPTOMYCIN | Hikma Pharmaceuticals USA Inc. | 23f39005-3008-4ab1-918d-b8acb001554e | 2026-03-23 | Warnings, Adverse reactions | 209949 NDA209949 |
| Daptomycin | DAPTOMYCIN | Xellia Pharmaceuticals USA LLC | 97c47c18-985d-4373-88f7-a86ec591ea44 | 2024-04-08 | Warnings, Adverse reactions | 209949 NDA209949 70594-053 |
| Daptomycin | DAPTOMYCIN | Civica, Inc. | bcacf746-a3ee-48b5-bfbe-6a2b548ad24c | 2024-04-05 | Warnings, Adverse reactions | 209949 NDA209949 72572-100 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0409-5933 | Daptomycin | Daptomycin | Hospira Inc. | NDA | Current |
| 0409-5933 | Daptomycin | DAPTOMYCIN | Hospira Inc. | NDA | Current |
| 45932-0039 | Daptomycin | Daptomycin | Xellia Pharmaceuticals USA, LLC | NDA | Current |
| 63323-585 | Daptomycin | Daptomycin | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-585 | Daptomycin | Daptomycin | Fresenius Kabi USA, LLC | NDA | Current |
| 70594-053 | Daptomycin | Daptomycin | Xellia Pharmaceuticals USA LLC | NDA | Current |
| 70594-053 | Daptomycin | Daptomycin | Xellia Pharmaceuticals USA LLC | NDA | Current |
| 70594-053 | Daptomycin | Daptomycin | Xellia Pharmaceuticals USA LLC | NDA | Current |
| 72572-100 | Daptomycin | Daptomycin | Civica, Inc. | NDA | Current |
| 72572-100 | Daptomycin | Daptomycin | Civica, Inc. | NDA | Current |
| 72572-100 | Daptomycin | Daptomycin | Civica, Inc. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 82144 | SUPPL | 2025-05-05 |
| 82288 | SUPPL | 2025-04-30 |
| 75698 | SUPPL | 2023-10-10 |
| 75684 | SUPPL | 2023-10-10 |
| 67433 | SUPPL | 2021-05-07 |
| 67428 | SUPPL | 2021-05-06 |
| 67427 | SUPPL | 2021-05-06 |
| 66244 | SUPPL | 2021-02-17 |
| 60043 | SUPPL | 2019-09-19 |
| 60036 | SUPPL | 2019-09-19 |
| 52675 | ORIG | 2018-02-20 |
| 50180 | ORIG | 2017-10-25 |
| 50130 | ORIG | 2017-10-23 |